Should You Buy This Blue Chip Biotech Stock?
This is arguably the most difficult time to be an income investor in decades. For one, the S&P 500 is yielding less than 1.3%, which is very close to its all-time low of 1.1% set back in 2000. Along with this, last month's annual inflation rate of 6.2% set a 31-year high. Anyone sitting on cash and waiting for a market correction is like watching your money go down the drain as your capital loses purchasing power. So, what is an income investor to do?
Fortunately, there are still viable high-yield options for income investors to consider. Let's take a look at three reasons why pharma stock AbbVie (NYSE: ABBV) could be one of those options.
Image source: Getty Images.
Source Fool.com
